Curve founder requests 17.45M CRV (~$6.6M) grant to fund development
Curve founder Michael Egorov proposed a 17.45 million CRV grant (~$6.6M) to Swiss Stake AG to fund core protocol development, maintenance and ecosystem support through 2026. The proposal, posted to the Curve DAO governance forum, would extend prior funding approved in late 2024 and preserve a 25-person development team focused on software R&D, security, infrastructure, smart-contract maintenance, lending technology (including Llamalend V2), an on-chain FX product (FXSwap), crvUSD and cross-chain integrations, plus UI improvements. Swiss Stake AG may stake unused CRV in liquid lockers (e.g., Convex, Yearn) to generate yield under grant terms; tokens cannot be spent on unrelated activities. Any IP produced will be released under an open-source license compatible with Curve’s codebase. Swiss Stake AG will publish biannual spending reports. Voting is open through Dec. 22, 2025, and early votes favored the proposal. At publication CRV had modest intraday gains after rebounding from multi-week lows; the vote outcome could affect DAO treasury allocations and CRV token dynamics. For traders: approval would secure dedicated developer capacity, likely supporting product road‑map execution and may be mildly bullish for CRV over the medium term by reducing execution risk and signalling continued protocol investment, while rejection or delays could raise uncertainty around development cadence and be a negative catalyst.
Neutral
The proposal secures funding for core development and maintenance, which reduces execution risk and supports roadmap delivery — factors that are generally positive for token fundamentals. The option to stake unused CRV in liquid lockers could also generate yield and modestly lower selling pressure if yields are retained. Early favorable votes and modest intraday price gains suggest limited positive sentiment. However, the grant is not an immediate on‑chain economic event like token burns or buybacks; its market impact depends on DAO voting, implementation, and transparency of spending. If approved, the news is likely mildly bullish to neutral for CRV over the medium term by improving development continuity and product rollout prospects. If rejected or delayed, uncertainty around development capacity could be a short-term negative. Therefore, the expected price impact is neither strongly bullish nor bearish immediately — traders should monitor voting outcomes, reported expenditures, and any CRV staking/locker flows for more direct price signals.